logo_no_tag_2c.jpg
Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel
August 11, 2022 16:05 ET | Sientra, Inc.
SANTA BARBARA, Calif., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
Straits Research Pvt Ltd
Medical Aesthetics Market Size is projected to reach USD 138.64 Billion by 2030, growing at a CAGR of 9.5%: Straits Research
August 11, 2022 15:59 ET | Straits Research
New York, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Medical Aesthetics is a field of medicine that focuses on procedures and techniques that improve the skin's appearance, texture, and...
2019 logo_150x35_jpg.jpg
Novan Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 11, 2022 06:30 ET | Novan, Inc.
– Total revenue of $6.2 million for the second quarter 2022 – – Activities on track for submission of berdazimer gel, 10.3% (SB206) New Drug Application (NDA), targeting submission before the...
Global Skin Health/Dermatology Functional Foods Market Report 2022: Development of Different Techniques to Create High-Value Natural Carotenoids Presents Opportunities
August 11, 2022 05:58 ET | Research and Markets
Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Skin Health/Dermatology Functional Foods Market by Indication (Skin Conditions, Anti-Aging, Anti-Allergy), Region (North America, Europe, Asia Pacific,...
Arcutis logo.png
Arcutis Announces Second Quarter 2022 Financial Results and Provides Business Update
August 04, 2022 16:01 ET | Arcutis Biotherapeutics, Inc.
Received U.S. Food and Drug Administration (FDA) approval for ZORYVE™ (roflumilast) cream 0.3% for the treatment of plaque psoriasis, including intertriginous psoriasis, in individuals 12 years of age...
2019 logo_150x35_jpg.jpg
Novan to Report Second Quarter 2022 Financial Results on August 11, 2022
August 04, 2022 09:05 ET | Novan, Inc.
DURHAM, N.C., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its second quarter 2022 financial results on Thursday,...
Arcutis logo.png
Arcutis Completes Enrollment in INTEGUMENT-1 Pivotal Phase 3 Trial of Roflumilast Cream in Atopic Dermatitis
August 04, 2022 08:00 ET | Arcutis Biotherapeutics, Inc.
A total of 654 adults and children, age six and older, have been enrolled in the INTEGUMENT-1 trialEnrollment continues in INTEGUMENT-2 with topline data from both trials expected by end of 2022Atopic...
Arcutis logo.png
Arcutis to Host Investor Conference Call Today to Discuss the FDA Approval of ZORYVE™ (roflumilast) Cream 0.3% for Plaque Psoriasis
August 01, 2022 07:30 ET | Arcutis Biotherapeutics, Inc.
WESTLAKE VILLAGE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an early-stage commercial biopharmaceutical company focused on developing meaningful...
logo_no_tag_2c.jpg
Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022
July 28, 2022 08:30 ET | Sientra, Inc.
SANTA BARBARA, Calif., July 28, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of...
researchdrivelogo.jpg
Dermacosmetics Market Expected to Register $13,0460.6 Million and Grow at 11.1% CAGR During the 2022-2030 Forecast Timeframe [350-Pages] | Reveals by Research Dive
July 19, 2022 09:04 ET | Research Dive
New York, USA, July 19, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global dermacosmetics market is expected to register a revenue of $130,460.6 million by 2030...